Moderna's decision comes a day after the FDA said it would require new clinical trials for approval of annual COVID-19 boosters for healthy people under 65.
Cheaper generic Ozempic is coming to Canada after Novo Nordisk fails to maintain patent in this country
- yesterday, 8:36 AM
- nationalpost.com
- 0
No comments